p53 and disease: when the guardian angel fails

J.A. Royds, Barry Iacopetta

Research output: Contribution to journalArticle

126 Citations (Scopus)

Abstract

The p53 tumor suppressor gene (TP53) is mutated more often in human cancers than any other gene yet reported. Of importance, it is mutated frequently in the common human malignancies of the breast and colorectum and also, but less frequently, in other significant human cancers such as glioblastomas. There is also one inherited cancer predisposing syndrome called Li-Fraumeni that is caused by TP53 mutations. In this review, we discuss the significance of p53 mutations in some of the above tumors with a view to outlining how p53 contributes to malignant progression. We also discuss the usefulness of TP53 status as a prognostic marker and its role as a predictor of response to therapy. Finally, we outline some evidence that abnormalities in p53 function contribute to the etiology of other non-neoplastic diseases.
Original languageEnglish
Pages (from-to)1017-1026
JournalCell Death and Differentiation
Volume13
DOIs
Publication statusPublished - 2006

Fingerprint Dive into the research topics of 'p53 and disease: when the guardian angel fails'. Together they form a unique fingerprint.

Cite this